Literature DB >> 22182671

Altered calcium regulation by thermosensitive transient receptor potential channels in etoposide-resistant WERI-Rb1 retinoblastoma cells.

Stefan Mergler1, Yating Cheng, Sergej Skosyrski, Fabian Garreis, Piotr Pietrzak, Norbert Kociok, Abhilash Dwarakanath, Peter S Reinach, Vinodh Kakkassery.   

Abstract

Differences in transient receptor potential (TRP) and cannabinoid receptor type 1 (CB1) expression levels can serve as prognostic factors for retinoblastoma (RB) tumor progression. We hypothesized in RB tissue that such differences are also indicators of whether or not they are sensitive to etoposide. Accordingly, we compared in malignant etoposide-sensitive and etoposide-resistant WERI-Rb1 cells TRPV1, TRPM8 and TRPA1 subtype and CB1 gene expression pattern levels and accompanying functional activity using quantitative real-time RT-PCR, immunohistochemistry, immunofluorescence microscopy, calcium imaging as well as patch-clamp technology. Gene expression patterns were evaluated in enucleated human RB tissues (n = 4). Both etoposide-resistant and etoposide-sensitive WERI-Rb1 cells expressed all of the aforementioned channels based on responses to known activators and thermal challenges. However, TRPA1 was absent in the etoposide-resistant counterpart. Even though both types of RB cells express TRPV1 as well as TRPM8 and CB1, the capsaicin (50 μM) (CAP)-induced Ca(2+) rise caused by TRPV1 activation was prompt and transient only in etoposide-resistant RB cells (n = 8). In this cell type, the inability of CB1 activation (10 μM WIN) to suppress Ca(2+) responses to CAP (50 μM; n = 4) may be attributable to the absence of TRPA1 gene expression. Therefore, using genetic approaches to upregulate TRPA1 expression could provide a means to induce etoposide sensitivity and suppress RB cell tumorigenesis.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22182671     DOI: 10.1016/j.exer.2011.12.002

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  14 in total

1.  Calcium regulation by thermo- and osmosensing transient receptor potential vanilloid channels (TRPVs) in human conjunctival epithelial cells.

Authors:  Stefan Mergler; Fabian Garreis; Monika Sahlmüller; Ekaterini-Maria Lyras; Peter S Reinach; Abhilash Dwarakanath; Friedrich Paulsen; Uwe Pleyer
Journal:  Histochem Cell Biol       Date:  2012-02-12       Impact factor: 4.304

2.  Protein Profiling of WERI-RB1 and Etoposide-Resistant WERI-ETOR Reveals New Insights into Topoisomerase Inhibitor Resistance in Retinoblastoma.

Authors:  Vinodh Kakkassery; Timo Gemoll; Miriam M Kraemer; Thorben Sauer; Aysegül Tura; Mahdy Ranjbar; Salvatore Grisanti; Stephanie C Joachim; Stefan Mergler; Jacqueline Reinhard
Journal:  Int J Mol Sci       Date:  2022-04-06       Impact factor: 5.923

3.  Expression Changes and Impact of the Extracellular Matrix on Etoposide Resistant Human Retinoblastoma Cell Lines.

Authors:  Jacqueline Reinhard; Natalie Wagner; Miriam M Krämer; Marvin Jarocki; Stephanie C Joachim; H Burkhard Dick; Andreas Faissner; Vinodh Kakkassery
Journal:  Int J Mol Sci       Date:  2020-06-17       Impact factor: 5.923

4.  A Novel Model of Cancer-Induced Peripheral Neuropathy and the Role of TRPA1 in Pain Transduction.

Authors:  Ahmad Maqboul; Bakheet Elsadek
Journal:  Pain Res Manag       Date:  2017-12-28       Impact factor: 3.037

5.  Vascular Endothelial Growth Factor (VEGF) Induced Downstream Responses to Transient Receptor Potential Vanilloid 1 (TRPV1) and 3-Iodothyronamine (3-T1AM) in Human Corneal Keratocytes.

Authors:  Ersal Türker; Fabian Garreis; Noushafarin Khajavi; Peter S Reinach; Pooja Joshi; Tobias Brockmann; Alexander Lucius; Nina Ljubojevic; Elizabeth Turan; Drew Cooper; Felix Schick; Rob Reinholz; Uwe Pleyer; Josef Köhrle; Stefan Mergler
Journal:  Front Endocrinol (Lausanne)       Date:  2018-11-22       Impact factor: 5.555

Review 6.  Polymodal roles of transient receptor potential channels in the control of ocular function.

Authors:  Peter S Reinach; Weiwei Chen; Stefan Mergler
Journal:  Eye Vis (Lond)       Date:  2015-03-02

Review 7.  Ocular transient receptor potential channel function in health and disease.

Authors:  Peter S Reinach; Stefan Mergler; Yuka Okada; Shizuya Saika
Journal:  BMC Ophthalmol       Date:  2015-12-17       Impact factor: 2.209

Review 8.  3-Iodothyronamine, a Novel Endogenous Modulator of Transient Receptor Potential Melastatin 8?

Authors:  Noushafarin Khajavi; Stefan Mergler; Heike Biebermann
Journal:  Front Endocrinol (Lausanne)       Date:  2017-08-16       Impact factor: 5.555

9.  3-Iodothyronamine Activates a Set of Membrane Proteins in Murine Hypothalamic Cell Lines.

Authors:  Julia Bräunig; Stefan Mergler; Sabine Jyrch; Carolin S Hoefig; Mark Rosowski; Jens Mittag; Heike Biebermann; Noushafarin Khajavi
Journal:  Front Endocrinol (Lausanne)       Date:  2018-09-11       Impact factor: 5.555

10.  TRPM8 Activation via 3-Iodothyronamine Blunts VEGF-Induced Transactivation of TRPV1 in Human Uveal Melanoma Cells.

Authors:  Lia Walcher; Clara Budde; Arina Böhm; Peter S Reinach; Priyavathi Dhandapani; Nina Ljubojevic; Markus W Schweiger; Henriette von der Waydbrink; Ilka Reimers; Josef Köhrle; Stefan Mergler
Journal:  Front Pharmacol       Date:  2018-11-13       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.